A trial of position control therapy fortreatment of infantile gastrooesophagealreflux.

Phase 3

Recruiting

• Conditions: infantile gastrooesophagealreflux (GOR) disease; infantile gastrooesophageal; reflux (GOR) disease; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12609000988257
• Lead Sponsor: Children Women Youth Health Service

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-11-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Symptoms considered to be related to GOR such as crying, irritablility, feed refusal, vomiting/spilling, gagging.

Exclusion Criteria

History of acute life threatening events or resectional surgery of the gastrointestinal tract or any condition that may require surgery during the length of the study, environmental exposure to cigarette smoke

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of GOR episodes as recorded by 24h ph/impadance.[14 days after randomisation]

Secondary Outcome Measures

Name	Time	Method
the gastric emptying rate will be asessed using the 13-C octanoate breath test.[14 days after randomisation]